First human tests begin for potential new pain drug
Knowledge-focused
Completed
This early study tested a new oral drug called AFA-281 in healthy volunteers to see if it is safe and how the body processes it. The study had two parts: first giving single doses, then giving multiple daily doses for up to three weeks. Researchers measured side effects, heart fu…
Phase: PHASE1 • Sponsor: Afasci Inc • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC